. Author manuscript; available in PMC: 2020 Sep 1.

Published in final edited form as: Cancer. 2019 May 8;125(17):3013–3024. doi: 10.1002/cncr.32162

Table 3c.

Multivariate Cox Model for MSS: E1690 Trial Data (HDI Versus Observation)

	HR	95% CI	P^a
Ulceration vs no ulceration	1.43	(1.13–1.81)	.003
Age ≥49 y vs <49 y	1.22	(0.96–1.54)	.099
Recurrent disease vs primary disease	1.18	(0.94–1.50)	.16

Abbreviations: HDI, high-dose interferon-α; HR, hazard ratio; MSS, melanoma-specific survival.

P value was derived from a Cox model.